Ganesh Palapattu
George F and Sandra G Valassis Professor of Urology
Professor of Urology and Chair
Department of Urology
[email protected]

Available to mentor
Ganesh Palapattu
Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Global REACH
    • Center Member
      Rogel Cancer Center
    • Center Member
      MM-PKUHSC Joint Institute
    Recent Publications See All Publications
    • Journal Article
      Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis.
      Singhal U, Nallandhighal S, Tosoian JJ, Hu K, Pham TM, Stangl-Kremser J, Liu C-J, Karim R, Plouffe KR, Morgan TM, Cieslik M, Lucianò R, Shariat SF, Finocchio N, Dambrosio L, Doglioni C, Chinnaiyan AM, Tomlins SA, Briganti A, Palapattu GS, Udager AM, Salami SS. Nat Commun, 2024 May 21; 15 (1): 4341 DOI:10.1038/s41467-024-48629-y
      PMID: 38773085
    • Journal Article
      Serum Androgens as Predictive Biomarkers: Results From a Randomized Clinical Trial Comparing Enzalutamide and Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer.
      Ternov KK, Fode M, Sønksen J, Bisbjerg R, Lindberg H, Palapattu G, Bratt O, Østergren PB. Clin Genitourin Cancer, 2024 Dec; 22 (6): 102200 DOI:10.1016/j.clgc.2024.102200
      PMID: 39244832
    • Journal Article
      Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.
      Tosoian JJ, Zhang Y, Xiao L, Xie C, Samora NL, Niknafs YS, Chopra Z, Siddiqui J, Zheng H, Herron G, Vaishampayan N, Robinson HS, Arivoli K, Trock BJ, Ross AE, Morgan TM, Palapattu GS, Salami SS, Kunju LP, Tomlins SA, Sokoll LJ, Chan DW, Srivastava S, Feng Z, Sanda MG, Zheng Y, Wei JT, Chinnaiyan AM, EDRN-PCA3 Study Group . JAMA Oncol, 2024 Jun 1; 10 (6): 726 - 736. DOI:10.1001/jamaoncol.2024.0455
      PMID: 38635241
    • Proceeding / Abstract / Poster
      PD45-04 DOES DRE ADD VALUE TO THE AUA PROSTATE CANCER RISK STRATIFICATION?
      Krischak M, Kaffenberger S, Montgomery J, Palapattu G, Borza T, Semerjian A, Salami S, Morgan T, Stensland K. Journal of Urology, 2024 May; 211 (5S): e968 DOI:10.1097/01.ju.0001008792.09108.b4.04
    • Journal Article
      Differences in mutations across tumour sizes in clear-cell renal cell carcinoma.
      Monda SM, Carney BW, May AM, Gulati S, Salami SS, Chandrasekar T, Keller ET, Huebner NA, Palapattu GS, Dall'Era MA. BJU Int, 2024 Sep 12; DOI:10.1111/bju.16527
      PMID: 39263870
    • Journal Article
      Opioid Consumption, Experience of Pain, and Satisfaction with Pain Management After Robot-Assisted Radical Prostatectomy: USA versus Denmark
      Jacobsen FM, Ostergren PB, Dupree JM, Moore M, Fode M, Berg KD, Jakobsen H, Ohl DA, Palapattu G, Sonksen J, Jensen CFS. Urologic Nursing, 2024 44 (3): 105 DOI:10.7257/2168-4626.2024.44.3.105
    • Journal Article
      What's in a Name? Why Words Matter in Advanced Prostate Cancer.
      Oh WK, Agarwal N, Bryce A, Barata P, Bugler C, Carlsson SV, Cornell B, Dahut W, George D, Loeb S, Montgomery B, Morris D, Mucci LA, Omlin A, Palapattu G, Riaz IB, Ryan C, Schoen MW, Washington SL, Gillessen S. Eur Urol, 2024 Oct 28; DOI:10.1016/j.eururo.2024.10.017
      PMID: 39472202
    • Journal Article
      Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype.
      Farha M, Nallandhighal S, Vince R, Cotta B, Stangl-Kremser J, Triner D, Morgan TM, Palapattu GS, Cieslik M, Vaishampayan U, Udager AM, Salami SS. Cancers (Basel), 2023 Nov 22; 15 (23): DOI:10.3390/cancers15235530
      PMID: 38067234